Heterogeneity in costs of standard-of-care drug regimens within high volume Enhancing Oncology Model disease groups: Implications for performance risk outside of a provider’s control.

Authors

null

Katherine Baker

Vanderbilt-Ingram Cancer Center, Nashville, TN

Katherine Baker, Garrett Young, Larry Edward Bilbrey, Samyukta Mullangi, Aaron J. Lyss, Natalie R. Dickson, Leah Owens, Stephen Matthew Schleicher

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship

Sub Track

Value-Based Models of Care

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 70)

DOI

10.1200/OP.2023.19.11_suppl.70

Abstract #

70

Poster Bd #

C23

Abstract Disclosures